Mission
NRx brings hope:
Life-saving medicines
For people living with unmet medical needs.
We believe in a world where scientific advancement makes untreatable diseases treatable.
NRx Team
Stephen Willard
Chief Executive Officer & Director
Jonathan C. Javitt, M.D., M.P.H.
Chairman and Chief Scientist
Richard Narido
Chief Financial Officer
Rick Panicucci, Ph.D.
Chief Technology Officer
Matthew Duffy
Chief Business Officer
Martin Brecher, M.D., DMSc, MBA
Medical Director
M. Daniel Gordin, Ph.D.
Regulatory Affairs Officer
Board of Directors
Patrick Flynn
Audit Committee Chair
Chaim Hurvitz
Jonathan C. Javitt, M.D., M.P.H.
Chairman and Chief Scientist
Stephen Willard
Chief Executive Officer & Director
Janet Rehnquist
Corporate Governance
Advisors
Prof. Daniel C. Javitt, M.D., Ph.D.
Co-founder & Chair, Scientific Advisory Board
Philip T. Lavin, Ph.D.
Chief Methodologist
Prof. Marion Leboyer, M.D., Ph.D
Principal Investigator (EU)
Dennis K. McBride, Ph.D.
Chief Strategy Officer & Senior Scientist
Melvin L. Morganroth, M.D.
Clinical Advisor
Andrew Nierenberg, M.D.
Principal Investigator
Harry B. Peled, M.D. FACC, CCS, CCS-P, HEC-C
Clinical Advisor
Wayne Pines
Regulatory & Patient Advocacy Advisor